N/A
N=362
Hot Snare Versus Hot Snare Polypectomy With Saline Injection for Colorectal Polyps
Polyp of Large Intestine
Bottom Line
View on ClinicalTrials.gov: NCT02239536 ↗Enrolled (actual)
362
Serious AEs
0.0%
Results posted
Apr 2020
Primary outcome: Primary: Complete Resection Rate — 161; 148; 6; 7 Participants — p=0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- hot snare polypectomy (Procedure); hot snare polypectomy after saline injection (Procedure)
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- All
- Sponsor
- Bo-In Lee
- Primary completion
- Dec 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Complete Resection Rate |
161; 148; 6; 7 | 0.05 |
| SECONDARY Lateral Margin |
83; 116; 3; 2; 91; 37 | 0.05 |
Summary
The complete removal of colorectal polyp is required to prevent tumor recurrence and development of potential interval cancers. However, several studies have shown high incomplete resection rate in endoscopic removal of neoplastic colorectal polyps larger than 5 mm. The polypectomy techniques using hot snare are usually used for the removal of these polyps. However, the optimal technique for complete resection of these polyps is unknown. There are few data comparing hot snare polypectomy with hot snare polypectomy after saline injection for complete resection of colorectal polyps (5mm or larger). The aim of this study is to compare hot snare polypectomy with hot snare polypectomy after saline injection for removal of 5-10mm sized colorectal polyps.
Eligibility Criteria
Inclusion Criteria
- Patients over the age of 30
- 5~10mm sized colorectal polyps
- Informed consent
Exclusion Criteria
- Inflammatory bowel diseases (Crohn's disease, or ulcerative colitis)
- Patient undergoing antiplatelets (aspirin, clopidogrel and others) or anticoagulant therapy
- ASA class III or more
- Any condition which, in the opinion of the Investigator, places the patient at unacceptable risk if he/she were to participate in the study
Data sourced from ClinicalTrials.gov (NCT02239536). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.